CMR–Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis-Reference-Cited by-同舟云学术

CMR–Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis

Published:2018-01 Issue:1 Volume:11 Page:38-45
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Lurz Julia Anna,Luecke Christian,Lang David,Besler Christian,Rommel Karl-Philipp,Klingel Karin,Kandolf Reinhard,Adams Volker,Schöne Katharina,Hindricks Gerhard,Schuler Gerhard,Linke Axel,Thiele Holger,Gutberlet Matthias,Lurz Philipp

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference35 articles.

1. Remodelling the extracellular matrix in development and disease;Bonnans;Nat Rev Mol Cell Biol,2014

2. Cardiac fibrosis: the fibroblast awakens;Travers;Circ Res,2016

3. Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential [published correction appears in Eur J Heart Fail 2015;17:985];Heymans;Eur J Heart Fail,2015

4. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy;Lehrke;Heart,2011

5. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography;Leong;Eur Heart J,2012

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymmetric Myocardial Involvement as an Early Indicator of Cardiac Dysfunction in Pediatric Dystrophinopathies: A Study on Cardiac Magnetic Resonance (CMR) Parametric Mappings;Pediatric Cardiology;2024-04-30

2. Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials;2024-02-07

3. The Clinical Evolution of Diffuse Myocardial Fibrosis in Patients With Arterial Hypertension and Heart Failure With Mildly Reduced Ejection Fraction Treated by Olmesartan or Sacubitril / Valsartan;Kardiologiia;2023-12-26

4. Risk stratification in patients with structurally normal hearts: Does fibrosis type matter?;PLOS ONE;2023-12-20

5. Longitudinal Changes in the Myocardial T1 Relaxation Time, Extracellular Volume Fraction, and Left Ventricular Function in Asymptomatic Men;Journal of Cardiovascular Development and Disease;2023-06-09